DEADLINE ALERT for CDNA, SPRO, LMPX, IONQ: The law firms of Howard G. Smith remind investors to… | New

0

BENSALEM, Pa., July 14. 10, 2022 (GLOBE NEWSWIRE) — The Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly traded companies. Investors have until the deadlines listed below to file as lead plaintiff.

Investors experiencing losses on their investments are encouraged to contact the law offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email at [email protected]

CareDx, Inc. (NASDAQ: CDNA)

Course period: February 24, 2021 – May 5, 2022

Lead Applicant Deadline: July 22, 2022

The Complaint alleges that throughout the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose that: (1) CareDx engaged in a variety of improper and illegal schemes to inflate revenue and demand for testing services, including pushing surveillance protocol through inaccurate marketing materials, offering outrageous inducements or bribes to physicians and other providers, and inappropriately bundling expensive testing services along with other blood tests under the RemoTraC service; (2) these practices, and others, have subjected CareDx to undisclosed risk of regulatory scrutiny; (3) these practices artificially inflated the Company’s reported testing services revenues throughout the Class Period; and (4) as a result, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

Spero Therapeutics, Inc. (NASDAQ: SPRO)

Course period: October 28, 2021 – May 2, 2022

Lead Applicant Deadline: July 25, 2022

The Complaint alleges that throughout the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose that: (1) the data submitted in support of the NDA Tebipenem HBr was insufficient to obtain FDA approval; (2) as a result, the FDA was unlikely to approve the Tebipenem HBr NDA in its current form; (3) the foregoing would require significant downsizing and restructuring of Spero’s business; and (4) as a result, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

LMP Automotive Holdings, Inc. (NASDAQ:LMPX)

Course period: June 29, 2021 – May 19, 2022

Lead Applicant Deadline: July 26, 2022

The Complaint alleges that throughout the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose: (1) that the Company engaged in the identification and elimination inappropriate B2B transactions; (2) that the Company used incorrect estimates for chargeback reserves for financial and insurance products; (3) that the Company had misclassified certain items in its financial statements, which had an impact on the legends of the financial statements of the balance sheet and the income statement; (4) that there were material weaknesses in LMP’s internal control over financial reporting; (5) that as a result of the foregoing, the Company has overstated its revenues; (6) that as a result of the foregoing, the Company would restate certain of its previously published financial statements and results; and (7) that as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis.

IonQ, Inc. (NYSE: IONQ)

Course period: March 30, 2021 – May 2, 2022

Lead Applicant Deadline: August 1, 2022

The Complaint alleges that throughout the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose: (1) that IonQ had not yet developed a 32 qubits; (2) that the company’s 11-qubit quantum computer suffered from high error rates, rendering it useless; (3) that IonQ’s quantum computer is not reliable enough, so it is not accessible although it is available through major cloud providers; (4) that a significant portion of IonQ’s revenue was derived from improper back and forth transactions with related parties; and (5) that as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

To be a member of these class actions, you do not have to take any action at this time; you can retain the services of a lawyer of your choice or do nothing and remain an absentee member of the class action. If you would like to know more about these class actions, or if you have any questions about this announcement or your rights or interests in these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith , 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by phone at (215) 638-4847, toll free at (888) 638-4847, or by email at [email protected], or visit our website at www.howardsmithlaw.com.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethics rules.

contacts

Law Firms of Howard G. Smith

Howard G. Smith, Esquire

215-638-4847

888-638-4847

[email protected]

www.howardsmithlaw.com

Share.

Comments are closed.